BOSTON, June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched ...
Haemonetics HAE recently announced that patients have been treated with the VASCADE MVP Venous Vascular Closure system in Germany. This marks the first use of the VASCADE system portfolio in a ...
Haemonetics Corporation HAE recently announced the full market release of its VASCADE MVP XL — a mid-bore venous closure system. The VASCADE MVP XL system will now be available to U.S. hospitals as ...
BOSTON, Aug. 29, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, has ...
BOSTON, Aug. 15, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, today ...
BOSTON, March 30, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results